The effect of Lavender planet in the treatment on tremor of Multipl Sclerosis patients.

The study of the effectivness of iranian lavender on tremor of Multipl Sclerosis patients: (Randomized controlled trial)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016082429511N1

Enrollment

Unknown

Registered

2016-09-17

Start date

2016-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. G35

Interventions

Intervention 1: Control group: placebo, oral capsule, Once a day for 8 weeks, made by Barijessence Pharmaceutical Factory. Intervention 2: Intervention group: Iranian Lavender oil, 80 mg oral capsule,

Placebo

Treatment - Drugs

Control group: placebo, oral capsule, Once a day for 8 weeks, made by Barijessence Pharmaceutical Factory

Intervention group: Iranian Lavender oil, 80 mg oral capsule, Once a day for 8 weeks, made by Barijessence Pharmaceutical Factory

Eligibility

Sex/Gender

All

Age

15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Including criteria: 1:Having proven MS according to the clinical examination and medical history 2:EDSS rating between 2 to 5.5 3:Having constant and regular medical treatment in the past 4 weeks 4:Consent to use of alternative medicines 7 days before the start of intervention to the end of intervention 5:Not be in another study at the same time 6:Age 15 to 50 years Excluding criteria: 1:History of alcohol or drug dependence 2:pregnancy or Breastfeeding 3:Impaired renal and/or liver function 4:Treatment with steroids over a month before the start of the study 5:Having a neurological disease in addition to multiple sclerosis 6: Having Cardiovascular or Lung disease( such as Asthma) or Diabetes 7:Allergy to Lavender

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Tremor. Timepoint: Questionnair :before the intervention, after four weeks of intervention and after the intervention / Tremor measuring machine: before the intervention and after the intervention. Method of measurement: Questionnair:Tremor part from MDS-UDPRS/ Tremor measuring machine(Motion Capture System).	—

Secondary

Measure	Time frame
Drug Side effects. Timepoint: Four weeks after the intervention, after intervention. Method of measurement: Oral questions from patients.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGolakeh Karimi

Ahvaz Jundishapur Univercity of Medical Miences

info@ajums.ac.ir ; g.karimi93@gmail.com+98 61 3374 3012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026